Workflow
VYNE Therapeutics (VYNE) - 2021 Q3 - Earnings Call Presentation

| --- | --- | --- | --- | --- | --- | |---------------------------------------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | InhiBET™ BET Inhibitor Platform | | | | | | | VYN201 Preclinical Study Update November 10, 2021 | | | | | | | | | | | | | | | | | | | | Forward Looking Statements 2 This presentation includes forw ...